This inventor holds 3 USPTO granted patents. Top assignee: Leland Stanford Junior University. Active years: 2004-2012.
Company Filing History:
Years Active: 2004-2012
Title: Anjali Pathak: Innovating Stem Cell Recruitment
Introduction
Anjali Pathak, an accomplished inventor based in Campbell, CA, has made significant contributions to the field of regenerative medicine. With a total of three patents to her name, Pathak's innovative work focuses on the recruitment of stem cells to treat various medical conditions.
Latest Patents
One of Anjali Pathak's latest patents is centered on "Nicotine Receptor Agonists in Stem Cell and Progenitor Cell Recruitment." This invention introduces methods for recruiting bone marrow-derived stem cells, including endothelial cell precursors and hematopoietic stem cells, through the administration of nicotine or other nicotine receptor agonists. These methods hold potential for treating conditions that can benefit from the recruitment of these stem cells, such as neutropenia. Notably, this groundbreaking work emphasizes the therapeutic advantages of targeting nicotine receptors in the stem cell recruitment process.
Career Highlights
Currently, Anjali Pathak is associated with Leland Stanford Junior University, a prestigious research institution known for its innovative approaches and groundbreaking discoveries in science and technology. Her work at the university has further solidified her position as a leading inventor in the field of regenerative medicine.
Collaborations
Pathak collaborates with other distinguished professionals in her field, including John P. Cooke and Frances Lauri Johnson. These collaborations have enriched her research and have contributed to the development of novel strategies for enhancing stem cell therapy.
Conclusion
Anjali Pathak is a remarkable inventor whose innovative research on stem cell recruitment through nicotine receptor agonists represents a significant advancement in regenerative medicine. As she continues her work at Leland Stanford Junior University, her contributions are poised to impact the medical community and provide new avenues for treating various hematological conditions.